These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12173723)

  • 21. Practical application of the 10-mg warfarin initiation nomogram.
    Wells PS; Le Gal G; Tierney S; Carrier M
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):403-8. PubMed ID: 19521238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computer aided warfarin dosing in the Swedish national quality registry AuriculA - Algorithmic suggestions are performing better than manually changed doses.
    Grzymala-Lubanski B; Själander S; Renlund H; Svensson PJ; Själander A
    Thromb Res; 2013 Feb; 131(2):130-4. PubMed ID: 23232091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of dental patients on warfarin therapy in a primary care setting.
    Chugani V
    Dent Update; 2004 Sep; 31(7):379-82, 384. PubMed ID: 15485118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction; the LoWASA Study.
    Herlitz J; Holm J; Peterson M; Karlson BW; Haglid Evander M; Erhardt L;
    Eur Heart J; 2004 Feb; 25(3):232-9. PubMed ID: 14972424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal initial dose adjustment of warfarin in orthopedic patients.
    Lenzini PA; Grice GR; Milligan PE; Gatchel SK; Deych E; Eby CS; Burnett RS; Clohisy JC; Barrack RL; Gage BF
    Ann Pharmacother; 2007 Nov; 41(11):1798-804. PubMed ID: 17911206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreasing warfarin sensitivity during the first three months after heart valve surgery: implications for dosing.
    Meijer K; Kim YK; Schulman S
    Thromb Res; 2010 Mar; 125(3):224-9. PubMed ID: 19336266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical inquiries. Does combining aspirin and warfarin decrease the risk of stroke for patients with nonvalvular atrial fibrillation?
    Robertson SL; Mayer JB; Guthmann R
    J Fam Pract; 2004 Jul; 53(7):570-5. PubMed ID: 15251100
    [No Abstract]   [Full Text] [Related]  

  • 28. Monitoring of anticoagulant therapy applying a dynamic statistical model.
    Nielsen PB; Lundbye-Christensen S; Larsen TB; Kristensen SR; Hejlesen OK
    Comput Methods Programs Biomed; 2013 Jun; 110(3):380-8. PubMed ID: 23305998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Warfarin can be safe and effective in the extreme elderly.
    Khan S; Myers K
    Age Ageing; 2009 Nov; 38(6):763; author reply 763-4. PubMed ID: 19749202
    [No Abstract]   [Full Text] [Related]  

  • 30. Increased warfarin doses and decreased international normalized ratio response after nationwide generic switching.
    Halkin H; Shapiro J; Kurnik D; Loebstein R; Shalev V; Kokia E
    Clin Pharmacol Ther; 2003 Sep; 74(3):215-21. PubMed ID: 12966365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra-arterial thrombolysis in patients treated with warfarin.
    Linfante I; Reddy AS; Andreone V; Caplan LR; Selim M; Hirsch JA
    Cerebrovasc Dis; 2005; 19(2):133-5. PubMed ID: 15637435
    [No Abstract]   [Full Text] [Related]  

  • 32. Approaches to optimal dosing of vitamin K antagonists.
    Witt DM
    Semin Thromb Hemost; 2012 Oct; 38(7):667-72. PubMed ID: 22893509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticoagulation management in hip fracture patients on warfarin [Injury 2005;36:1311-5].
    Tharmarajah P
    Injury; 2006 Oct; 37(10):1029-30; author reply 1030-1. PubMed ID: 16934264
    [No Abstract]   [Full Text] [Related]  

  • 34. Hemorrhagic events lead to an increase in international normalized ratio in patients on warfarin.
    Perona S; Ford M; Rindone J
    J Pharm Pract; 2011 Oct; 24(5):494-7. PubMed ID: 22156711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Peroral anticoagulant treatment--are the INR values reliable?].
    Eilertsen H; Dagre AT; Ulveland K
    Tidsskr Nor Laegeforen; 2000 Feb; 120(5):618. PubMed ID: 10833924
    [No Abstract]   [Full Text] [Related]  

  • 36. Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial.
    Van Spall HG; Wallentin L; Yusuf S; Eikelboom JW; Nieuwlaat R; Yang S; Kabali C; Reilly PA; Ezekowitz MD; Connolly SJ
    Circulation; 2012 Nov; 126(19):2309-16. PubMed ID: 23027801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further evidence of a clinically significant levofloxacin-warfarin interaction.
    Glasheen JJ; Prochazka AV
    South Med J; 2008 Jun; 101(6):660; author reply 660. PubMed ID: 18475216
    [No Abstract]   [Full Text] [Related]  

  • 38. Warning label added to common blood thinner: how to stay safe.
    Johns Hopkins Med Lett Health After 50; 2007 Mar; 19(1):1, 8. PubMed ID: 17342838
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
    Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
    J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.
    Meijer K; Kim YK; Carter D; Schulman S
    Thromb Haemost; 2011 Feb; 105(2):232-8. PubMed ID: 21173999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.